A open label, randomized, controled trial to assess the usefulness of telmisartan in patients with type 2 diabetes, obesity, and NAFLD.
Not Applicable
Recruiting
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000002641
- Lead Sponsor
- MATSUYAMA SHIMIN HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients whose fatty liver is difficult to evaluate. (A heavy drinker, other liver diseases, etc.) 2) Patients requiring hospitalization to attain glycemic control. 3) Patients judged inadequate to participate in this study by their physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Content of visceral fat and fatty liver
- Secondary Outcome Measures
Name Time Method HbA1c, fasting glucose, fasting CPR, ABI/PWV, body weight, blood pressure